Table 1.
Clinicopathological characteristics of cats grouped according to SDMA status
SDMA within RI (n = 107) | n | SDMA above RI (n = 36) | n | P value | |
---|---|---|---|---|---|
SDMA (1‐14 μg/dL) | 10 [10, 11] | 107 | 15 [15, 19] | 36 | |
Age (years) | 12.2 [11.2, 14.5] | 107 | 14 [12.1, 15.3] | 36 | .66 |
Weight (kg) | 4.35 [3.36, 5.08] | 107 | 4.01 [3.02, 4.85] | 36 | .22 |
BCS (1‐9) | 5 [4, 6] | 107 | 5 [3, 5] | 36 | .19 |
MCS (0‐2) | 1 [1, 2] | 105 | 1 [1, 1] | 36 | .06 |
Sex (male n [%]) | 40 | 107 | 54 | 36 | .25 |
PCV (%) | 38 [25, 40] | 106 | 35 [33, 40] | 36 | .12 |
Creatinine (0.23‐2.00 mg/dL) | 1.49 [1.31, 1.67] | 107 | 1.76 [1.59, 1.89] | 36 | <.001 |
FGF23 (56‐700) pg/mL) | 155 [127, 243] | 107 | 271 [176, 523] | 36 | <.001 |
PTH (2.6‐17.6 pg/mL) | 7 [2.6, 11.3] | 44 | 7.3 [4.1, 9.3] | 10 | .84 |
Phosphate (2.71‐6.89 mg/dL) | 3.66 [3.22, 4.12] | 107 | 3.84 [3.28, 4.18] | 36 | .40 |
Total calcium (8.22‐11.82 mg/dL) | 9.7 [9.3, 10.1] | 107 | 9.98 [9.5, 10.18] | 36 | .70 |
Total magnesium (1.73‐2.57 mg/dL) | 2.14 [2.04, 2.26] | 36 | 1.97 [1.87, 2.21] | 5 | .62 |
Note: Data presented as median [25th, 75th percentile] or prevalence (n [%]).
Abbreviations: BCS, body condition score; FGF23, fibroblast growth factor 23; MCS, muscle condition score; PCV, packed cell volume; PTH, parathyroid hormone; RI, reference interval; SDMA, symmetric dimethylarginine.